Loading...
Market
What will be the outcome of the trial against the three remaining defendants in Baltimore's opioid litigation?
2
Resolution / Starting Odds
All defendants found liable • 25%
Some defendants found liable • 25%
None of the defendants found liable • 25%
Mixed verdicts • 25%
Court verdict or official announcements from the City of Baltimore
Story
Baltimore Settles with Teva, Walgreens for $160 Million in Opioid Crisis, Totaling $402.5 Million
Sep 10, 2024, 08:37 PM
The City of Baltimore has reached settlements with Teva Pharmaceuticals and Walgreens, totaling $160 million, for their roles in the city's opioid crisis. The settlement with Teva amounts to $80 million, while the settlement with Walgreens also amounts to $80 million. These settlements, announced on Monday and Tuesday, are part of a larger effort by Baltimore to address the opioid crisis, with the city securing a total of $402.5 million from various drug companies. The settlements come ahead of a trial scheduled to begin next week against the three remaining defendants in the litigation.
View original story
Similar markets
Yes • 50%
No • 50%
McKesson • 25%
AmerisourceBergen • 25%
Johnson & Johnson • 25%
Other • 25%
Financial settlement reached • 25%
Case dismissed • 25%
Case goes to trial • 25%
Other • 25%
In favor of Bayer AG • 25%
Against Bayer AG • 25%
Settled out of court • 25%
Mistrial • 25%
Appeal successful • 25%
Appeal partially successful • 25%
Appeal unsuccessful • 25%
No appeal filed • 25%
Settlement approved • 33%
Settlement rejected • 33%
Settlement still under negotiation • 33%
Yes • 50%
No • 50%
Settlement • 25%
Trial verdict • 25%
Dismissal • 25%
Other • 25%
Bayer wins • 25%
Plaintiff wins • 25%
Case settled • 25%
Case dismissed • 25%